Additionally, we found that ANXA9 could transfer the S100A4 out of cancer cells (Fig. 7A, B) and down regulation of ANXA9 could decreased the cytokines of IL-6, IL-8, CCL2, and CCL5 (Fig. 7C). Here, S100A4 is linked to cancer.